★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Boston Scientific Corporation vs Medtronic plc

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$70.9B
Gross margin (TTM)70.4%
Operating margin (TTM)20.1%
Net margin (TTM)17.2%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-07-12
Moat score
66/ 100

Partial score covering 85% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Medtronic plc

MDT · New York Stock Exchange

Market cap (USD)$99B
Gross margin (TTM)62%
Operating margin (TTM)17.9%
Net margin (TTM)13%
SectorHealthcare
IndustryMedical - Devices
CountryIE
Data as of2026-07-12
Moat score
71/ 100

Partial score covering 76% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Medtronic plc's moat claims, evidence, and risks.

View MDT analysis

Comparison highlights

  • Segment focus: Boston Scientific Corporation has 4 segments (66% in Cardiovascular); Medtronic plc has 4 segments (38.6% in Cardiovascular Portfolio).
  • Moat breadth: Boston Scientific Corporation has 3 moat types across 2 domains; Medtronic plc has 4 across 2.

Primary market context

Boston Scientific Corporation

Cardiovascular

Market

Cardiovascular devices (interventional cardiology, vascular therapies, structural heart, electrophysiology, cardiac rhythm management, remote monitoring, and interventional oncology/embolization)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists, vascular specialists, interventional radiologists/oncologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

66%

Medtronic plc

Cardiovascular Portfolio

Market

Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)

Geography

Global

Customer

Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons

Role

Device OEM + procedure support + remote monitoring software/services

Revenue share

38.6%

Side-by-side metrics

Boston Scientific Corporation
Medtronic plc
Ticker / Exchange
BSX - New York Stock Exchange
MDT - New York Stock Exchange
Market cap (USD)
$70.9B
$99B
Gross margin (TTM)
70.4%
62%
Operating margin (TTM)
20.1%
17.9%
Net margin (TTM)
17.2%
13%
Sector
Healthcare
Healthcare
Industry
Medical - Devices
Medical - Devices
HQ country
US
IE
Primary segment
Cardiovascular
Cardiovascular Portfolio
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
66 / 100 (partial, 85% coverage)
71 / 100 (partial, 76% coverage)
Moat domains
Demand, Legal
Demand, Network
Last update
2026-07-12
2026-07-12

Moat coverage

Shared moat types

Installed Base Consumables

Boston Scientific Corporation strengths

Training Org Change CostsRegulated Standards Pipe

Medtronic plc strengths

Data Workflow LockinDesign In QualificationEcosystem Complements

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

14.5%

Urology

Competitive

13.5%

Neuromodulation

Oligopoly

6%

Cardiovascular

Oligopoly

66%

Medtronic plc segments

Full profile >

Cardiovascular Portfolio

Oligopoly

38.6%

Neuroscience Portfolio

Oligopoly

28.4%

Medical Surgical Portfolio

Competitive

24.4%

MiniMed / Diabetes (consolidated all other)

Oligopoly

8.6%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like BSX and MDT, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.